Varicose Veins Treatment Devices Market 2021-2027 | Share, Growth, Post COVID-19 Impact analysis By Alma Lasers, AngioDynamics, VVT Med, F care systems

Publisher: The Insight Partners

The global varicose veins treatment devices market accounted to US$ 512.6 Mn in 2017 and is expected to grow at a CAGR of 9.6% during the forecast period 2018 - 2025, to account to US$ 1032.4 Mn by 2025.

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period. North American market is driven by the factors such as, increasing number of manufacturers as well as the large number of surgeries such as, new product launches by market players and high population suffering with venous diseases in the region.

Request Exclusive Sample PDF of this Report @ https://www.theinsightpartners.com/sample/TIPHE100001235/?source=smartmarketnews.live-10425

The List of Companies

Alma Lasers
AngioDynamics
VVT Med
F care systems
Asclepion Laser Technologies GmbH
Syneron Medical Ltd.
Energist Ltd.
Medtronic
biolitec AG
Miravas

Market Insights

Increasing Incidence of Chronic Venous Diseases

The disease is highly prevalent among the adult population worldwide generating sustainable burden of the global healthcare spending. The increasing incidence of the venous diseases such as varicose veins can thus increase the growth of global varicose veins treatment market. According to the American Society for Vascular Surgery (ASVS) 2015, at least 20 to 25 million Americans have varicose veins. Statistics further show that 17% of men and 33% of women have varicose veins. In fact, more people are unable to work due to vein disorders than due to arterial disease. According to a survey report published by Sigvaris, in industrialized countries, over 30% of women and about 10% of men consult physicians for venous signs and symptoms of the legs.

Strategic Insights

Product launches and approvals were observed as the most adopted strategy in global varicose veins treatment devices industry. Few of the launches and approvals made by the players in the market are listed below:

2017: In November, 2017, The US Centers for Medicare and Medicaid Services (CMS) approved insurance coverage for VenaSeal procedures.

2015: In November, 2015, The company launched its VenaSeal closure system for treating varicose veins in the lower extremities. The company uses a proprietary medical adhesive to close superficial veins in lower extremities in patients with symptomatic venous reflux, or varicose veins.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the varicose veins treatment devices market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global varicose veins treatment devices market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Purchase Full Copy of This Report @ 

https://www.theinsightpartners.com/buy/TIPHE100001235/?source=smartmarketnews.live-10425

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876
Email: sales@theinsightpartners.com